MedPath

Open-angle Glaucoma Subjects on One Ocular Hypotensive Medication Randomized to Treatment With Two Trabecular Micro-bypass Stents or Selective Laser Trabeculoplasty

Not Applicable
Completed
Conditions
Open-angle Glaucoma
Registration Number
NCT01444105
Lead Sponsor
Glaukos Corporation
Brief Summary

Evaluation of intraocular pressure (IOP) lowering effect of two iStent stents versus a SLT procedure in subjects with open-angle glaucoma on one ocular hypotensive medication.

Detailed Description

Evaluation of intraocular pressure (IOP) lowering effect of two iStent stents versus a SLT procedure in subjects with open-angle glaucoma on one ocular hypotensive medication.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Phakic study eye or study eye with a posterior chamber intraocular lens (PC-IOL)
  • Primary open-angle glaucoma (including pseudoexfoliative)
Exclusion Criteria
  • Aphakic or pseudophakic with anterior chamber IOLs (AC-IOLs) (study eye)
  • Prior stent implantations (study eye)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change from baseline in mean diurnal IOP (mm Hg) at the Month 12 visit.12 Months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

S.V. Malayan Ophthalmological Center

🇦🇲

Yerevan, Armenia

S.V. Malayan Ophthalmological Center
🇦🇲Yerevan, Armenia

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.